Please login to the form below

Free Thinking: Are biosimilars the answer to the rising cost of RA treatment?


In a past Free Thinking paper, we looked at the opportunity and challenges for biosimilar mAbs entering the rheumatoid arthritis market. A few years later and according to our Therapy Watch patient record data, uptake of biosimilars remains relatively muted, with marked inconsistencies across the major European markets. With Enbrel biosimilar Benepali about to launch across EU, we ask what’s next for RA?

http://www.researchpartnership.com/news/2016/04/ft-are-biosimilars-the-answer-to-the-rising-cost-of-...


3rd June 2016

Share

Tags

Company Details

Research Partnership

+44 (0)20 8069 5000

Contact Website

Address:
Chester House
Fulham Green
81-83 Fulham High Street
London
SW6 3JW
United Kingdom

Latest content on this profile

Live from Singapore: Exploring the opportunity for women’s health in emerging markets
Join global healthcare market research consultants Pei Li Teh and Wan Ling Neo for this complimentary webinar in which they will explore the opportunity for women’s health in emerging markets.
Research Partnership
Men vs Women in emerging markets
Our latest interactive infographic compares male vs female health characteristics in the BRIC emerging marketS
Research Partnership
South Korea: The next global player?

Research Partnership
20 questions: Round 4

Research Partnership
Will gene therapies finally be commercially viable to pharma?

Research Partnership
Wargaming in HCV

Research Partnership